No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data.
We investigated for which doses a significantly increased tumor rate can be seen in the RERF Life Span Study data sets on mortality or incidence of solid tumors. No significant increase was found below about 200 mSv.